Voices
Majid Al Othman: POSEIDON Meta-Analysis Results in Post-Prostatectomy Salvage RT
Majid Al Othman/LinkedIn

Majid Al Othman: POSEIDON Meta-Analysis Results in Post-Prostatectomy Salvage RT

Majid Al Othman, Unit Head of Radiation Oncology at Johns Hopkins Aramco Healthcare (JHAH), shared a post on LinkedIn:

“Simultanous with ASCO GU 26, the POSEIDON metaanalysis of adding ADT to salvage post-prostatectomy salvage RT shows benefit only if pre-RT PSA is >0.5, with 4-6 mo duration being adequate.

However, consider 24 mo if PSA >1.6.”

Title: Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

Authors: Amar Kishan, Yilun Sun, Christopher Parker, Paul Sargos, Matthew Sydes, Sylvie Chabaud, Meryem Brihoum, Tahmineh Romero Kalbasi, Michael Steinberg, Luca Valle, Kekoa Taparra, Jonathan Shoag, Jorge Garcia, Jason Brown, Matthew Rettig, Adam Singer, Robert Reiter, Scott Eggener, Wayne Brisbane, Soumyajit Roy, Nicholas Zaorsky, Angela Jia, Ting Ma, Nicholas Nickols, Jason Efstathiou, Osama Mohamad, James Dignam, Wendy Seiferheld, Alan Pollack, Howard Sandler, Paul Nguyen, Pascal Pommier, Daniel Spratt

Read the Full Article.

Majid Al Othman: POSEIDON Meta-Analysis Results in Post-Prostatectomy Salvage RT

Other articles featuring Majid Al Othman on OncoDaily.

Adam Singer Alan Pollack Amar Kishan Angela Jia ASCO GU 26 cancer Christopher Parker Daniel Spratt Howard Sandler James Dignam Jason Brown Jason Efstathiou Jonathan Shoag Jorge Garcia Kekoa Taparra Luca Valle Majid Al Othman Matthew Rettig Matthew Sydes Meryem Brihoum Michael Steinberg Nicholas Nickols Nicholas Zaorsky OncoDaily Oncology Osama Mohamad Pascal Pommier Paul Nguyen Paul Sargos POSEIDON Robert Reiter Scott Eggener Soumyajit Roy Sylvie Chabaud Tahmineh Romero Kalbasi Ting Ma Wayne Brisbane Wendy Seiferheld Yilun Sun